IDH1 and acute myeloid leukemia: However, as expected, use of the two different generic GEMs generated different profiles of the MGPs; for example, for the AML samples, the use of Recon 2M.2 predicted more MGPs with IDH than Human1 (Figs. 3a and 6a).